ICA1 is a 69 kDa protein encoded by the ICA1 gene, localized in the cytosol and membrane-bound forms on the Golgi complex and secretory vesicles . It functions in membrane trafficking and synaptic plasticity . As an autoantigen, ICA1 is associated with:
The ICA1 antibody detects this protein in research and diagnostic assays, aiding studies on autoimmune mechanisms and neurodegenerative pathways.
ICA1 antibodies are widely used in:
Notable Commercial Antibodies:
| Supplier | Clonality | Host | Reactivity | Applications |
|---|---|---|---|---|
| Novus Biologicals | Polyclonal | Rabbit | Human | WB, IHC, IHC-Paraffin |
| R&D Systems | Polyclonal | Goat | Human, Mouse | WB, IHC, Flow Cytometry |
| Bio-Techne | Monoclonal | Mouse | Human | IP |
Type 1 Diabetes: ICA1 autoantibodies correlate with T1D progression, driven by IgG1/IgG3 isotypes .
Genetic Regulation: Polymorphisms in the ICA1 promoter increase binding of the autoimmune regulator (AIRE), reducing ICA1 expression in thymic cells and breaking immune tolerance .
Alzheimer’s Disease (AD): ICA1 levels are reduced in AD patients and mouse models. It modulates amyloid precursor protein (APP) processing via the PICK1-PKCα pathway, influencing β-amyloid production .
ICA69 (Immunoglobulin-like cell adhesion molecule 1) may play a role in neurotransmitter secretion.